Wednesday, February 12, 2025 3:50:51 PM
iclight,
Sorry I didn’t explain for you what cost averaging is. For example you decide to start an investment in NWBO at $.60 with the expectation that in 3 years the price will go to $5. Well the price drops a little so you buy the same amount at $.40. Well the price is being worked down even further while the company waits on a regulatory decision and the price goes to $.23 so you buy the same amount you did as each of the first two lots. So you add up the price of each lot and divide by the 3 equal sized lots and you get a cost basis of $.41. If there is an approval at this point the price reacts to news that draws in lots of speculators that a partnership will be announced or that at least partnership value can be maintained for a significant period of time which drives the price up over $1 immediately and then possibly beyond depending on news shared. At this point that $.41 looks like a really smart move and the start at $.60 was worth it while dealing with unknowns especially when during the intervening two years after news the price ended up being well more than $5. Most investors like that kind of math; ). Best wishes.
Sorry I didn’t explain for you what cost averaging is. For example you decide to start an investment in NWBO at $.60 with the expectation that in 3 years the price will go to $5. Well the price drops a little so you buy the same amount at $.40. Well the price is being worked down even further while the company waits on a regulatory decision and the price goes to $.23 so you buy the same amount you did as each of the first two lots. So you add up the price of each lot and divide by the 3 equal sized lots and you get a cost basis of $.41. If there is an approval at this point the price reacts to news that draws in lots of speculators that a partnership will be announced or that at least partnership value can be maintained for a significant period of time which drives the price up over $1 immediately and then possibly beyond depending on news shared. At this point that $.41 looks like a really smart move and the start at $.60 was worth it while dealing with unknowns especially when during the intervening two years after news the price ended up being well more than $5. Most investors like that kind of math; ). Best wishes.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
